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Attention deficit hyperactivity disorder (ADHD) is a weakening mental health problem that hampers the child 
development. Both the hereditary and ecological elements are the primary causes behind the challenge and possibly will be 
different among persons. The drugs are used for ADHD may be enhancing the health problem. Therefore, huge requirement 
of ayurvedic based foodstuff is anticipated among the end users that are expected to be healthy as well as afford additional 
functional benefits. An ayurvedic plant such as brahmi (Bacopamonnieri and Centellaasiatica) is reported to have much 
useful functional benefits. Brahmi is well-known to harness reminiscence, perception, being sensible and further mental 
disorderliness. The present review enlightens the functional properties of brahmi for children with ADHD, including 
intervention programme. 
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Mental disorder is now foremost thing a cause  
of disability in childhood1. Attention deficit 
hyperactivity disorder (ADHD) is an unbearable 
mental confusion that slows down the children’s 
growth2. It is among the commonest childhood stage 
neurobehavioral disorderliness and is known to 
intensely impact the scholastic performance, 
happiness and communal relationship of kids3. ADHD 
portray by persistent sign such as inattention, 
hyperactivity and impulsivity4. It has a universal 
occurrence with an estimated 6% incidence5 and is 
commonly identified in the age group of 2-7 years 
that is in preschool aged children.6 
As stated by World Health Organization (WHO), a 
cerebral disarray are to amplify by 50% in the year of 
two thousand and twenty, is the fore most finding root 
of morbidity in kids. The kids represent on 40% in 
India and the rate of psychopathology amid childhood 
is 5 to 15%. A recent analysis estimated that the 
global cumulative impact of mental disorder in terms 
of economic output will amount to US$ 1600 billion 
over next 20 year.7 
Numerous research have stated greatly variable 
rates of ADHD around the world, starting from as low 
as 1% to as high as almost 20% among school 
children8,9 and its noticeable in the ages of 6 and  
12 years10. The occurrence rate of ADHD in United 
State of America is 4 to 8%11, In Korea it is noticed to 
be 7.6% to 9.5%12 and 10 to 20% in India13 and 1 to 
17.7% in India14. The issue of ADHD disorder is a 
major threat among primary school children15, but 
continues into adulthood too16. 
The occurrence of ADHD between boys and girls 
differ around the world and the ratio ranged from 2:1 to 
6:1. The majority studies noticed that boys are more 
affected with ADHD than the girls17. In favor of above 
findings, USA reported a 3.62% of boys and 0.85% of 
girls faced ADHD out of 10,438 children who were 
assessed for the study18. A similar finding noticed in 
Colombia too, reported the occurrence in boys (19.8%) 
than girls (12.3%)19. The gender disparity in ADHD are 
more, this may be because of the girls with 
neurobehavioral disorder are undiagnosed20,21. 
The hereditary and the atmospheric surrounding are 
fore most position in etiology of ADHD and earlier 
research findings revealed about ADHD amongst 
identical twins (8%), fraternal twins (32%) and first-
degree relatives (25%). Environmental consequence 
such as maternal stress and smoking habit among 
family members during pregnancy, poor quality early 
care giving, prenatal complications and prematurity 
also plays a leading part. 
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The dimension of the brain construction for ADHD 
affected pupil is reduced roughly 5 to 10% and 
magnetic renounce imaging screened reduced blood 
level in striatum and shortage in functional networks22. 
The ADHD prime uniqueness are lack of 
concentration, tendency to act on a whim and restless 
and these personality will lead to lack of communal 
bond, acquisition of knowledge in the school and 
disturb other person as well23. The secondary 
personalities are difficulty to create bond with the peer 
group. In that case, this kind of personality kids may 
keep away from peer group and communal pupil24,25. 
The synthetic food additive, colours and chemical 
(salicylates) will enhance the restlessness26,27 and 
these findings tested by Stevens28. Appropriate diet is 
needed for kids and kids like to eat more of junk food 
and they face hyperactivity, this may reflect a long-
term nutritional imbalance29. Thus, advice to parents 
to polished grains, only energy rich foodstuff, sweets 
and preserved foodstuff, synthetic additives and 
colours must be avoided entirely from the foodstuff. 
Drugs are used in ADHD are psycho stimulants, 
tricyclic antidepressants and tranquilizers. These 
drugs may be enhancing the possibility of heart 
related problem, liver injury and other health issue30. 
Today the need came to find out effective treatment 
without hampering the development of health and 
psychology of children. Therefore, actual need of our 
natural medicine and several traditional based food 
products. In that case, the need for exploration of new 
foodstuff from naturally available source may 
enhance the cognition ability and earlier studies 
noticed that the ayurvedic plant such as 
Bacopamonnieri (BA) and Centellaasiacitica (CA) 
has potency to increase the mental function. 
 
Health benefits of ayurvedic plants 
Ayurveda, which is more than 5 thousand years 
older and it has a beneficial effect on nerve function 
(CNS) and increase the mental capability31,32,33. 
Nootropic plants are used to increase mental function, 
example of ayurvedic plant with nootropic activity 
such as Ginkgo biloba, B. monnieri, C. asiatica. 
Withaniasomnifera and Convolvulus Pluricaulis.  
The bramhi (C. asiatica. B.monnieri) which contain 
large amount of secondary metabolites providing 
active compounds stimulating cell upgrading, 
enhancephysical and mental health. Both plants 
(Bacopamonnieri and Centellaasiatica) possess 
neuroprotective properties, neurotropic action with 
beneficial application33. 
Bacopamonnieri 
Bacopa called brahmi includes 46 species, water in 
habitat and are found in hot zone of the globe 
including India, Nepal, Sri Lanka, China, Taiwan and 
Vietnam and parts of USA34. In India, it is found in 
soggy, muddy spot and grows well on the banks of 
unhurried flowing rivers and lakes upto an attitude of 
1,320 m. It is a small climber, fastly spreads and have 
succulent parts and has abundant branches and small 
fleshy, oblong leaves. Flowers and fruits appear  
in summer and the entire plant is medicinally 
important35,36.  
The group of plant therapeutic called 
medhyarasayana are well-known to boost mental 
health, intellect and memory (medhya) and are 
believed to prop up longevity and rejuvenation 
(rasayana)37. The brain, being the creative centre of 
humans35 is expected to be influenced by the brahmi 
as sanskrit name brahmi stems from Brahma-the 
creative aspect of God. B. monnieri is recognized for 
use over centuries as a brain tonic, memory enhancer, 
revitalize sensory organs. It is also further used as a 
medicine inanti-anxiety, as a cardio-tonic, diuretic, 
antidepressant and anticonvulsant agent36. It is very 
effectively used as an anti inflammatory, analgesic, 
antipyretic, epilepsy, anticancer therapeutics and is a 
good antioxidant38,39. Skin ailments such as eczema, 
psoriasis, abscess, ulcerations and leprosy are treated 
with the products made out of Bacopa in India and 
Pakistan. Further, it is also useful in treatment of 
chronic rheumatism as an ointment and to treat 
asthma and hoarseness in voice40.  
The Bacopa has a high moisture content (88%), 
carbohydrate (5.9%), fat (0.6%) and protein (2.1%). 
Plant secondary metabolites such as phenylethanoid 
glycosides, flavonoids, amino acids such as alpha-
alanine, aspartic acid, glutamic acid and betulinic 
acid, stigmasterol, b-sitosterol and stigmastrenol are 
registered in these plants41,42,35. 
The bioactive composites (bacoside A&B) and 
amino acids in these ayurvedic are increase the 
protein kinase action to produce protein and these 
protein may repair the damaged neurons43,44,45.  
The numerous study noticed that two main saponin 
(Bacoside A&B) enhance the learning ability in 
rats46,44,47,36. In adding up, bacoside A fraction is more 
faster than the bacoside B fraction48 and it plays 
foremost position to increase positive effect on  
mental function49 and this bioactive compound have 
antidepressant property as well50.  




Various study revealed that the presence of 
different tetra cyclic triterpenoid saponin is 
accelerating the cognition activity51,52. Numerous 
studies concluded that the bacosides are reported as a 
scavenger of free radicals53,54,55,56. 
The defensive reactions of the Bacopa plant extort 
on brain mitochondrial enzyme action in rats were 
well documented in previous studies57. The reaction 
of B. monnieri extort on the cognition performance 
while ageing was well documented58,59 and has a task 
in ayurvedic therapies for treating cognitive 
disorderliness during aging60. Studies on animal 
version has depicted their role in escalating memory 
competence and be with neuroprotectant action 
against Alzheimer’s disease61,62. Bacopamonnieri 
extract in the quantity of 300  mg/day for 6 weeks of 
administration on a group of people, the experiment 
exposed that the increasing technical evidence 
supporting the cognitive improvement effects63. In a 
study to treat aluminium induced oxidative stress, the 
neuro protective reaction of the B. monnieri in the 
hippocampus part of rat brain well evidently 
documented64. The extracts of B. monnieri give relief 
to patients affected with anxiety or epileptic 
disorders65,66,67,68. Epilepsy and hysteria is treated with 
medicated ghee from B. monnieri69. 
Sentence repetition and logical reminiscence were 
found to be dramatically improved in children who 
took Bacopa70. In yet another study use of Bacopa on 
children for 42 days, was exposed to boost the mean 
auditory and visualnotably.71 
 
Centella Asiatica 
Centellaasiatica L. (Gotu Kola) is a tropical 
medicinal plant and grows in India, China, Indonesia, 
Malaysia, Sri Lanka South Africa and Madagascar72. 
It is a nerve tonic and micronutrient in the plant extort 
was found to be accountable to retard brain aging and 
also assisted replenishment of neural tissue. Thus was 
believed to boost reminiscence and invigoratethe 
brain as well beyond increasing the attention span and 
concentration73. As an ayurvedic agent was used 
forcuring skin related troubles, laceration and 
rejuvenating the brain function74,75.  
C. asiatica has a wider health benefits and 
therefore, its use in food processing is found 
increasing over the years. It is registered in medicinal 
use as a potential antioxidant, known for 
antimicrobial, cytotoxic, neuroprotective properties as 
well and other activities too. It possesses bioactive 
constituents viz., triterpenic acid (asiatic acid 
madecassoside acid), triterpenic saponin (madecassoside 
and asiaticoside), flavonoids and further phenolic 
compounds76,77,78. The asiaticoside is the most 
plentiful triterpene glycoside, which, it enhance the 
antioxidant level in wound healing process79.  
Centella contains nearly eighty eight per cent of 
moisture, three hundred and ninety one milligram of 
potassium and one hundred and seventy one 
milligram of calcium (low in protein, carbohydrate 
and fat content). The brahmic acid, isobrahmic acid, 
brahminoside, and brahmoside present in C. asiatica 
have shown some psychotropic, sedative and 
anticonvulsant factors. It is useful to treat dementia, 
brain associated disorderliness and anxiety80. 
C. asiatica has been found to be efficient in 
opposition to diabetes mellitus81, depression82, 
wound-healing activity, antibacterial activity83, 
neuroprotective activity84. The intake of C. asiatica is 
useful to prevent oxidative damage. As a powerful 
antioxidant, it used as an important neuroprotective 
effect and provide protection to the rat's brain for age-
related oxidative damage85,86,87. The components in 
the ayurvedicis useful for enhancing renovate of 
injured neurons through hasten nerve regeneration84,88. 
Asiaticoside and brahmoside are found to hold 
anxiolytic activity through inhibition of phospholipase 
action in rat cerebellum89.  
The median lethal dose of dried powder of  
C. asiatica, given as an oral dose to mice, was found 
to be higher than 8 g/kg90. Further, Wistar rats (both 
sex) that received different doses of C. asiatica at 20, 
200, 600 and 1200 mg/kg/day for six months, let out 
no symptoms of important changes of body mass and 
blood analysis in comparison to control group91.  
 
Measure of medhyarasayana 
Bacopa can be taken in the form of non-
standardized powder (5-10 g), mixture (8-16 mL), and 
syrup (30 mL) in each day92. Dosages of a 1:2 
solution extort are in the range of 5-12 mL/day for 
adults whereas it was 2.5-6 mL/ day for kids ages  
6-1293. A Bacopa syrup preparation, equal to 1 g 
dehydrated Bacopa leaf at the daily basis for 3 months 
among 40 children in the ages of 6–8 years, showed 
strengthening, reminiscence perception and response 
performance and no side effects were reported94. Fifty 
four people (65 years) administrated 300 mg of 
Bacopamonnieri extract for twelve weeks and none of 
the participants had any sign of dementia or severe 
memory loss95. A an additional study, researchers 
gave participants aged 55 and above (person with 




memory loss) 125 mg/day of Bacopamonnieri extract 
for 12 weeks, noticeably better mental control, logical 
memory function, and paired association learning96.  
A usual each day quantity of C. asiatica 
approximately at 600 mg of dehydrated leaf or 
mixture, single-dose tablet, a 10-mg strong extort 
accessible in the form of tablet was found very 
effective97. Dehydrated leaves as a tea, by addition of 
5-10 g in bubbling hot water (150 mL) and allowed to 
sheer for 15 min and 3 cups /day was advisable. The 
systemized Centella extort have up to 100% total 
saponins (triterpenoids), 60 mg of extort 1 or 2/day, 
are regularly utilized in recent herbaceous medication. 
A few side effects such as skin allergy and burning 
sensations (with external use), headache, stomach 
upset, nausea, dizziness and drowsiness were 
reported, however, for a recommended dose no 
known toxicity was found98,99. 
 
ADHD interventions 
ADHD is more occurrences in primary school 
going children and it’s throughout the lifelong 
problems. This is the right time to give intervention 
programme to ADHD affected children. Teacher 
should know more about the ADHD than their 
parents, as they intermingle with kids for a more time 
than parent100. 
The educational intervention is to promote normal 
behavior and plan to enhance the school performance 
through improvement in education, concentration 
power, memory and behavior. The foremost thing of 
school intervention is to increase positive education 
outcome100. To strong the above evidence, educational 
intervention are effective to increase mental function 
amid children101. It is not control the behavior  
but improving habits and day to day activities  
which enhance the leaning power24. Moreover the 
intervention is based on atmosphere surroundings and 
mental ability to learn102 
ADHD is often treated with clinical interventions 
and behavioural interventions. Treatments for kids 
with ADHD may harmfully impact upon both 
communal and education performance103. The study 
argued that drug again and again, only helps 
aggravate 'symptoms', but do not help the youngster 
to task efficiently in academic level and it will lead to 
severe side effects with drug104. Thus, educational 
interventions consider as more desirable and effective 
strategies to treat ADHD disorder affected children105. 
ADHD in India, limited awareness is reported in 
the survey13,106. According to Wilcox, much families 
with ADHD either unknowing of the situation or 
unsure of the suffering itself107. A tiny concordance 
amid parents and teachers in acknowledgement 
ADHD may be a major reason behind these scenarios. 
A need is therefore to augment much research on 
ADHD in India108. 
 
Discussion  
Studies on different clinical and experimental trial 
reported that the ayurvedic plant has properties of 
nootropic, cognition enhancing, learning and 
neuroprotective properties. Bacopa posses the most 
enhancing capabilities to improve the mental ability, 
induce cognition function and positively modify 
behavior by increased level of serotonin and other 
neurotransmitters. Centella has property of increasing 
the learning capacity by induce dendriticarborization 
in amygdaloidal nucleus. There is positive result in 
clinical and experimental about bacopa and centella 
on ADHD. However, it’s a natural product, the 
challenge is to describe the mechanisms and paths 
intricate in the nootropic and retention improving 
roles stimulus by brahmi. The specific compounds 
from BM and CA such as bacosides, asiaticoside and 
asiatic acid are the revitalizing properties. In the field 
of the therapeutics, has been a continuous discrepancy 
amongst scientists using clean composites and 
persons using natural extracts. Hence, the upcoming 
of investigation in brahmi will be focus to molecular 
investigation of the properties of different composites 
vs natural extracts in interpolation bio assay effects and 
its health benefits.  
 
Conclusion  
Ayurvedic plant could deliver a flawless response 
to ADHD affected kids with harmless to health. 
Bacopamonniera Linn. (Brahmi) & Centellaasiatica 
Linn. (Mandookparni) is evidenced to control 
inattention and hyperactivity and thus pave way to 
further research to set up in a scientific manner. 
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